Research and development expenses were $0.9 million for each of the three months ended June 30, 2025 and June 30, 2024, as an increase in EB06-related expenses for Edesa’s planned Phase 2 vitiligo ...

JERUSALEM, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptide and protein replacement therapies, today reported financial results and key ...

NORTHAMPTON — In a near unanimous vote at the State House in Boston Thursday, a special commission charged with recommending ...

The former head of the US Food and Drug Administration is testing the Trump administration’s commitment to “Make America ...

Starting on August 5, Prime Minister Benjamin Netanyahu held a series of meetings with military and political leaders to discuss “options for continuing the campaign in Gaza,” his office said. The ...

When we asked readers if the city should declare a public health and safety emergency, the overwhelming majority of ...

Despite financial hurdles including tariffs, Maplewood-based health care supplier Solventum raised its revenue expectations Thursday as executives said momentum is growing for the newly public company ...

Our nation’s nurses face death threats and physical violence every day while saving patients' lives. Now, they’re at their ...

Ascherio said the university was able to pull together funding to pay his researchers’ salaries until next June. But he’s ...